Cost-effectiveness of screening and management strategies for chlamydia control in Hong Kong: abridged secondary publication
WCW Wong1, C Wong1,2, J Ong3,4,5, C Fairley3,5, J Hocking6
1 Department of Family Medicine and Primary Care, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2 Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
3 Central Clinical School, Monash University, Australia
4 Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
5 Melbourne Sexual Health Centre, Alfred Health, Australia
6 Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia
- Chlamydia trachomatis is the most common bacterial sexually transmitted infection worldwide. Untreated infections can lead to onward transmission and serious complications.
- Cost and staff attitude are the most important factors for patients to test and treat chlamydia, respectively.
- Targeted testing with strengthened contact tracing is the most cost-effective way to reduce the prevalence of chlamydia in the general population.
- Upskilling primary care to identify at-risk individuals may improve efficiency and cost-effectiveness of any future chlamydia testing programmes in Hong Kong.